US stock futures are higher by 2.7% as well as the stock of Gilead the drug company said to be developing a medicine that could help battle the coronavirus outbreak.
Gilead Sciences is up 12.5 percent in pre-market trading at around $86.38 per share, after reports suggested that its investigation
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
